Liu Han, Da Wacili, Mu Jianhua, He Xuanhong, Li Zhuangzhuang, Gong Taojun, Wang Jingjing, Min Li, Lu Minxun, Tu Chongqi
Department of Orthopedics, Orthopaedic Research Institute, West China Hospital, Sichuan University, Chengdu, China.
Department of Orthopedics Surgery, Orthopeadic Research Institute, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, China.
Front Genet. 2024 Dec 9;15:1519529. doi: 10.3389/fgene.2024.1519529. eCollection 2024.
Platelets are associated with poor prognosis in most tumors, but their specific pathogenic mechanism in osteosarcoma is not yet clear. The objective of this study is to conduct an in-depth analysis of how genes closely related to platelet function impact the prognosis of osteosarcoma patients. We hope that through this research, we can uncover the potential mechanisms of these genes in the development and progression of osteosarcoma, thereby providing new therapeutic strategies and theoretical foundations for improving the prognosis of osteosarcoma patients.
We collected the blood routine test data of patients who were initially diagnosed with osteosarcoma at the Department of Bone Tumors, West China Hospital, from January 2012 to January 2022. By applying the LASSO-COX regression analysis, a statistical method, we found that the platelet count is associated with the prognosis of osteosarcoma patients. To further explore this relationship, we obtained single-cell data and bulk RNA data of osteosarcoma patients from the TARGET database and GEO database, respectively. By analyzing these data, we revealed at the transcriptomic level how platelets contribute to the poor prognosis in osteosarcoma patients.
Platelets are associated with the prognosis of osteosarcoma patients (HR = 3.9, 95% CI = 1.9-8.1, < 0.001). Through the analysis of transcriptomic data from the TARGET database and GEO database, we found significant heterogeneity in tumor-specific pathways and immune infiltration under different platelet-related gene expression patterns. Among these, TBXAS1 was identified as a key gene that affects the prognosis of osteosarcoma patients. In addition, single-cell data analysis showed that the platelet-related gene TBXAS1 is mainly enriched in macrophages, and markers of macrophages are significantly associated with poor prognosis in osteosarcoma patients.
TBXAS1 is a key platelet-related gene that leads to poor prognosis in osteosarcoma, and this gene may affect the prognosis of osteosarcoma patients by interacting with macrophages.
血小板在大多数肿瘤中与预后不良相关,但其在骨肉瘤中的具体致病机制尚不清楚。本研究的目的是深入分析与血小板功能密切相关的基因如何影响骨肉瘤患者的预后。我们希望通过这项研究,揭示这些基因在骨肉瘤发生发展过程中的潜在机制,从而为改善骨肉瘤患者的预后提供新的治疗策略和理论基础。
我们收集了2012年1月至2022年1月在华西医院骨肿瘤科室初诊为骨肉瘤患者的血常规检测数据。通过应用LASSO - COX回归分析这一统计方法,我们发现血小板计数与骨肉瘤患者的预后相关。为进一步探究这种关系,我们分别从TARGET数据库和GEO数据库获取了骨肉瘤患者的单细胞数据和批量RNA数据。通过分析这些数据,我们在转录组水平揭示了血小板如何导致骨肉瘤患者预后不良。
血小板与骨肉瘤患者的预后相关(HR = 3.9,95% CI = 1.9 - 8.1,P < 0.001)。通过对TARGET数据库和GEO数据库的转录组数据进行分析,我们发现在不同血小板相关基因表达模式下,肿瘤特异性通路和免疫浸润存在显著异质性。其中,TBXAS1被确定为影响骨肉瘤患者预后的关键基因。此外,单细胞数据分析表明,血小板相关基因TBXAS1主要富集于巨噬细胞,且巨噬细胞标志物与骨肉瘤患者的不良预后显著相关。
TBXAS1是导致骨肉瘤预后不良的关键血小板相关基因,该基因可能通过与巨噬细胞相互作用影响骨肉瘤患者的预后。